Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00692185 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa
A Phase 2 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 23
- Enrollment target
NCT00692185 is a Phase 2 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 23 participants.
The verdict
NCT00692185, a Phase 2 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of the antipsychotic medication olanzapine in treating outpatients with anorexia nervosa.
Interventions
- DRUG Placebo
- DRUG Olanzapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2005-10 |
| Est. Completion | 2010-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00692185
The ClinicalTrials.gov registry entry for NCT00692185 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00692185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00692185 about?
NCT00692185 is a clinical study titled "Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa". This study will evaluate the effectiveness of the antipsychotic medication olanzapine in treating outpatients with anorexia nervosa.
What is the current status of trial NCT00692185?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 23 participants. The study started on 2005-10. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00692185?
The interventions under investigation include: Placebo (DRUG), Olanzapine (DRUG).
Who is sponsoring clinical trial NCT00692185?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.